查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲精準醫療軟體市場：依產品類型、應用、最終用戶、國家 - 分析與預測（2024-2033）
市場調查報告書
商品編碼
1606243

歐洲精準醫療軟體市場：依產品類型、應用、最終用戶、國家 - 分析與預測（2024-2033）

Europe Precision Medicine Software Market: Focus on Product Type, Application, End User, and Country - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 58 Pages | 商品交期: 1-5個工作天內

價格

2024年歐洲精準醫療軟體市場規模為4.609億美元。

估計2024年至2033年該市場將以11.47%的年複合成長率成長，2033年達到12.247億美元。在歐洲市場，精準醫療軟體是指目的是支援醫療保健領域精準醫療實施的先進數位工具和應用程式。這種個體化方法著重於根據患者個體特徵（包括遺傳、生活方式、環境以及分子或細胞特徵）量身定做的治療和決策。

主要市場統計資料
預測期 2024-2033
2024年評估值 4.609億美元
2033年預測 12.247億美元
年複合成長率 11.47%

由於資料分析、基因組學和個人化醫療保健策略的市場開拓，歐洲精準醫療軟體市場顯著擴張。精準醫療軟體對於根據每位患者獨特的基因譜、生活方式和環境情況量身定做醫療選擇和治療非常重要。透過實現資料主導的決策，該技術可以改善患者的治療效果、治療效果和診斷準確性。

歐洲強大的醫療保健系統和對數位健康舉措的投資增加推動了精準醫療軟體的採用。透過Horizon Europe等計畫，歐洲各國政府和組織將基因研究和精準醫學作為首要任務，並推動該領域的創新。人工智慧（AI）和機器學習（ML）的整合進一步增強了軟體的功能，實現即時資料分析和客製化治療計劃。

在歐洲，藥物基因體學、慢性病管理、罕見疾病發現和腫瘤學是精準醫學軟體的主要用途。儘管存在資料隱私問題和高昂的實施成本等障礙，但隨著生物資訊學和巨量資料的市場開拓，對精準醫療的日益重視推動市場擴張。

本報告研究了歐洲精準醫療軟體市場，並提供了市場概況，包括依產品類型、應用、最終用戶、國家分類的趨勢，和參與市場的公司概況。

目錄

執行摘要

第1章 市場

  • 趨勢：當前和未來的影響評估
  • 供應鏈概覽
  • 監管狀況
  • 市場動態概覽

第2章 區域

  • 區域概況
  • 促進因素和抑制因素
  • 歐洲

第3章 市場競爭基準化分析及公司概況

  • 未來展望
  • 地理評估
    • F. Hoffmann-La Roche Ltd
    • Genedata AG
    • Koninklijke Philips NV
    • QIAGEN NV
    • SOPHiA GENETICS SA

第4章 調查方法

Product Code: BHP2405SS

Introduction to Europe Precision Medicine Software Market

The Europe precision medicine software market was valued at $460.9 million in 2024 and is expected to reach $1,224.7 million by 2033, growing at a CAGR of 11.47% between 2024 and 2033. In the Europe market, precision medicine software refers to advanced digital tools and applications designed to support the implementation of precision medicine in healthcare. This personalized approach focuses on tailoring medical treatments and decisions to individual patient characteristics, including genetics, lifestyle, environment, and molecular or cellular profiles.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$460.9 Million
2033 Forecast$1,224.7 Million
CAGR11.47%

The market for precision medicine software in Europe is expanding significantly due to developments in data analytics, genomics, and tailored healthcare strategies. In order to customize medical choices and treatments to each patient's unique genetic profile, lifestyle, and environmental circumstances, precision medicine software is essential. By enabling data-driven decision-making, this technology enhances patient outcomes, treatment effectiveness, and diagnostic precision.

Precision medicine software adoption is being accelerated by Europe's strong healthcare system and rising investments in digital health initiatives. Through programs like Horizon Europe, governments and organizations throughout the continent are giving genetic research and precision healthcare top priority, which is encouraging innovation in the field. The software's capabilities are further improved by the integration of artificial intelligence (AI) and machine learning (ML), which permits real-time data analysis and customized treatment planning.

In Europe, pharmacogenomics, chronic disease management, uncommon disease detection, and oncology are among the main uses of precision medicine software. The increased emphasis on precision healthcare, along with developments in bioinformatics and big data, is propelling market expansion despite obstacles such data privacy issues and high implementation costs.

The market for precision medicine software is expected to be crucial in improving patient care and advancing personalized medicine, as Europe continues to lead the world in the adoption of cutting-edge healthcare technologies.

Market Segmentation

Segmentation 1: by Delivery Mode

  • On-Premises Delivery Mode
  • Cloud-Based Delivery Mode

Segmentation 2: by Application

  • Oncology
  • Cardiovascular
  • Rare Diseases
  • Others

Segmentation 3: by End User

  • Healthcare Providers
  • Research Centers and Government Institutes
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

Segmentation 4: by Country

  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe precision medicine software market has been segmented based on various categories, such as product type, application, and end user.

Competitive Strategy: The Europe precision medicine software market is a highly fragmented market, with many smaller and private companies constantly entering the market. Key players in the precision medicine software market analyzed and profiled in the study involve established players that offer various kinds of products.

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • F. Hoffmann-La Roche Ltd
  • Genedata AG
  • Koninklijke Philips N.V.
  • QIAGEN N.V.
  • SOPHiA GENETICS SA

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Rise in Personalized Healthcare
    • 1.1.2 Cloud-Based Delivery Mode-Based Platforms Elevating Data Accessibility
  • 1.2 Supply Chain Overview
    • 1.2.1 Value Chain Analysis
  • 1.3 Regulatory Landscape
  • 1.4 Market Dynamics Overview
    • 1.4.1 Market Drivers
      • 1.4.1.1 Utilizing Artificial Intelligence and Precision Medicine Together
      • 1.4.1.2 Enhancement in the Precision Medicine Field Using Integrated and Automated Solutions
    • 1.4.2 Market Restraints
      • 1.4.2.1 Data Safety and Privacy Concerns
    • 1.4.3 Market Opportunities
      • 1.4.3.1 Leveraging Electronic Health Records in the Market

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Europe
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 Application
    • 2.3.5 Product
    • 2.3.6 France
    • 2.3.7 Germany
    • 2.3.8 U.K.
    • 2.3.9 Spain
    • 2.3.10 Italy
    • 2.3.11 Rest-of-Europe

3 Markets Competitive Benchmarking & Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Geographic Assessment
    • 3.2.1 F. Hoffmann-La Roche Ltd
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products/Product Portfolio
      • 3.2.1.3 Target Customers
      • 3.2.1.4 Key Personnel
      • 3.2.1.5 Analyst View
    • 3.2.2 Genedata AG
      • 3.2.2.1 Overview
      • 3.2.2.2 Top Products/Product Portfolio
      • 3.2.2.3 Target Customers
      • 3.2.2.4 Key Personnel
      • 3.2.2.5 Analyst View
    • 3.2.3 Koninklijke Philips N.V.
      • 3.2.3.1 Overview
      • 3.2.3.2 Top Products/Product Portfolio
      • 3.2.3.3 Target Customers
      • 3.2.3.4 Key Personnel
      • 3.2.3.5 Analyst View
    • 3.2.4 QIAGEN N.V.
      • 3.2.4.1 Overview
      • 3.2.4.2 Top Products/Product Portfolio
      • 3.2.4.3 Target Customers
      • 3.2.4.4 Key Personnel
      • 3.2.4.5 Analyst View
    • 3.2.5 SOPHiA GENETICS SA
      • 3.2.5.1 Overview
      • 3.2.5.2 Top Products/Product Portfolio
      • 3.2.5.3 Target Customers
      • 3.2.5.4 Key Personnel
      • 3.2.5.5 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Precision Medicine Software Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 2: Europe Precision Medicine Software Market (by Delivery Mode), $Million, 2023, 2027, and 2033
  • Figure 3: Europe Precision Medicine Software Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 4: Europe Precision Medicine Software Market (by End User), $Million, 2023, 2027, and 2033
  • Figure 5: Key Events of Precision Medicine Software Market, 2023 and 2024
  • Figure 6: Role of Precision Medicine Software in Personalized Care
  • Figure 7: Benefits of Using Cloud-Based Delivery Mode Technology in Healthcare
  • Figure 8: Supply Chain and Risks within the Supply Chain
  • Figure 9: Precision Medicine Software (by Year), January 2021-December 2023
  • Figure 10: Impact Analysis of Market Navigating Factors, 2023-2033
  • Figure 11: Benefits of Integrating AI with Precision Medicine
  • Figure 12: Two Key Strategies for Empowering Precision Medicine
  • Figure 13: France Precision Medicine Software Market, $Million, 2023-2033
  • Figure 14: Germany Precision Medicine Software Market, $Million, 2023-2033
  • Figure 15: U.K. Precision Medicine Software Market, $Million, 2023-2033
  • Figure 16: Spain Precision Medicine Software Market, $Million, 2023-2033
  • Figure 17: Italy Precision Medicine Software Market, $Million, 2023-2033
  • Figure 18: Rest-of-Europe Precision Medicine Software Market, $Million, 2023-2033
  • Figure 19: Strategic Initiatives, 2021-2023
  • Figure 20: Share of Strategic Initiatives, 2021-2023
  • Figure 21: Data Triangulation
  • Figure 22: Top-Down and Bottom-Up Approach
  • Figure 23: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: Precision Medicine Software Market Trend Analysis
  • Table 4: Cloud-Based Delivery Mode-Based Platform
  • Table 5: Role of EHRs in Advancing Precision Medicine
  • Table 6: Precision Medicine Software (by Region), $Million, 2023-2033
  • Table 7: Europe Precision Medicine Software Market (by Application), $Million, 2023-2033
  • Table 8: Europe Precision Medicine Software Market (by End User), $Million, 2023-2033
  • Table 9: Europe Precision Medicine Software Market (by Delivery Mode), $Million, 2023-2033